206 related articles for article (PubMed ID: 35015108)
21. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions.
Hung WL; Wu JF; Ni YH; Chen HL; Chiang CL; Chang MH; Hsu HY
Liver Int; 2019 Jun; 39(6):1052-1061. PubMed ID: 30790411
[TBL] [Abstract][Full Text] [Related]
22. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant.
Karthigesu VD; Allison LM; Ferguson M; Howard CR
J Med Virol; 1999 Aug; 58(4):346-52. PubMed ID: 10421400
[TBL] [Abstract][Full Text] [Related]
23. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
24. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
[TBL] [Abstract][Full Text] [Related]
25. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
[TBL] [Abstract][Full Text] [Related]
27. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
28. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
Qin Y; Liao P
Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
[TBL] [Abstract][Full Text] [Related]
31. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP; Yilmaz S; Gül C; Sengül A; Hacibektasoglu A; Van Thiel DH
J Viral Hepat; 1998 Jul; 5(4):265-9. PubMed ID: 9751013
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.
Shedain PR; Devkota MD; Banjara MR; Ling H; Dhital S
BMC Infect Dis; 2017 Oct; 17(1):667. PubMed ID: 29017456
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers.
Zhang Y; Bourgine M; Wan Y; Song J; Li Z; Yu Y; Jiang W; Zhou M; Guo C; Santucci D; Liang X; Brechot C; Zhang W; Charneau P; Wu H; Qiu C
J Hepatol; 2024 Jan; 80(1):31-40. PubMed ID: 37827470
[TBL] [Abstract][Full Text] [Related]
34. Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC; Peters CJ; Sureau C; Nio K; Li F; Su L; Jones JE; Isogawa M; Sallberg M; Frelin L; Peterson DL; Milich DR
Hum Vaccin Immunother; 2020; 16(2):251-268. PubMed ID: 31809638
[TBL] [Abstract][Full Text] [Related]
35. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk.
Bogomolski-Yahalom V; Granot E; Linder N; Adler R; Korman S; Manny N; Tur-Kaspa R; Shouval D
J Med Virol; 1991 Aug; 34(4):217-22. PubMed ID: 1834799
[TBL] [Abstract][Full Text] [Related]
37. Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.
Hu WG; Wei J; Xia HC; Yang XX; Li F; Li GD; Wang Y; Zhang ZC
World J Gastroenterol; 2005 Apr; 11(14):2088-94. PubMed ID: 15810073
[TBL] [Abstract][Full Text] [Related]
38. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring hepatitis B virus B-cell and T-cell epitope mutants in hepatitis B vaccinated children.
Lin YM; Jow GM; Mu SC; Chen BF
ScientificWorldJournal; 2013; 2013():571875. PubMed ID: 24379746
[TBL] [Abstract][Full Text] [Related]
40. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
